Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL‐60 leukemic cell line

International Journal of Cancer

Volumn 56, Issue 6, 1994, Pages 906-909

  Aviram, Adina ^a   Zimrah, Yael ^a   Shaklai, Mali ^a   Nudelman, Abraham ^b   Rephaeli, Ada ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HISTONE; PIVALOYLOXYMETHYL BUTYRATE; PIVALOYLOXYMETHYLBUTYRATE; PRODRUG; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL;

ACETYLATION; ANILINE COMPOUNDS; BUTYRATES; BUTYRIC ACID; BUTYRIC ACIDS; HISTONES; LEUKEMIA, PROMYELOCYTIC, ACUTE; ORGANOPHOSPHORUS COMPOUNDS; PRODRUGS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028219470     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910560625     Document Type: Article

References (27)

1. Esters of N,N‐disubstituted 2‐hydroxyacetamides as novel highly biolabile prodrug type for carboxylic acid agents
2. Sodium butyrate inhibits histone deacetylation in cultured cells
3. Rapid and reversible changes in nucleosome structure accompany the activation, repression and super‐induction of murine fibroblast protooncogenes c‐fos and c‐myc
4. Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds
5. Transcription and cancer
6. Retinoic acid inhibits sodium butyrate‐induced monocytic differentiation of HL‐60 cells while synergistically inducing granulocytoid differentiation
7. Dynamically acetylated histones of chicken erythrocytes are selectively methylated
8. Butyric acid: inhibition of non‐leukemic and chronic myeloid leukemia, granulocyte macrophage clonal growth
9. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications
10. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemia cells
11. Towards an understanding of the biological function of histone acetylation
12. Clinical pharmacology of sodium butyrate in patients with acute leukemia
13. Histone acetylation reduces nucleosome core particle linking number changes
14. Novel anticancer prodrugs of butyric acid
15. Histone hyperacetylation can induce unfolding of the nucleosome core particle
16. Modulation of thyroid hormone nuclear receptors by short chain fatty acids in glial C6 cells
17. Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation
18. Butyric acid: a small fatty acid with diverse biological functions
19. Rapid alteration of c‐myc and c‐jun expression in leukemic cells induced to differentiate by a butyric acid prodrug
20. Derivatives of butyric acid as potential anti‐neoplastic agents
21. Thyroid hormone nuclear receptor levels are influenced by the acetylation of chromatin‐associated proteins
22. Forskolin: a unique diterpene activator of cyclic AMP‐generating system
23. Patterns of histone acetylation
24. Butyrate suppression of histone deacetylation leads to accumulation of poly‐acetylated forms of H3 and H4 and increased DNase‐I sensitivity of associated DNA sequences
25. Other post‐translational modifications of proteins
26. Affinity chromatography of mammalian and yeast nucleosomes
27. Comparison of the effects of forskolin and dibutyryl cAMP in neuroblastoma cells: evidence that some of the actions of dibutyryl, cAMP are mediated by butyrate